Biotech Cannabis Stocks Continue to Outperform the Market

Investors and financial institutions have shown great interest for publicly traded cannabis companies, but many are afraid to invest in them because most trade on the over-the-counter (OTC) exchange. The OTC exchange, also known as the Pink Sheets, is comprised of startups, defunct public shell companies, scams, and a few good companies.

There are more than 300 publicly traded cannabis companies, but only a few trade on an exchange regulated by the SEC. The cannabis stocks that trade on a national exchange have outperformed the market during 2015 and we attribute some of this growth to the lack of investment opportunities available for investors and institutions. The cannabis related companies that trade on a national exchange include, but are not limited to the following:

  1. GW Pharmaceuticals (GWPH: NASDAQ)
  2. Insys Therapeutics, Inc. (INSY: NASDAQ)
  3. Zynerba Pharmaceuticals (ZYNE: NASDAQ)

GW Pharmaceuticals (GWPH: NASDAQ)

GW Pharmaceuticals is focused on developing cannabinoid-based...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
https://technical420.com/cannabis-article/biotech-cannabis-stocks-continue-outperform-market